BioSpace News Archive

Job Trends

MGIS Wins Yet Another Best Places to Work Award

The 2019 Best Places to Work in Insurance award is MGIS’s ninth recognition for workplace excellence and employee satisfaction

September 23, 2019
·
2 min read
Pharm Country

Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product

To date, Sandoz has not received any reports of adverse events related to use of the product as part of this recall.

September 23, 2019
·
3 min read
KILL Stimwave Launches Post-Market Peripheral Neuropathy Pain Relief Randomized Controlled Trial for Pain Awareness Month

The release was transmitted with an incorrect boilerplate for Stimwave by Stimwave Technologies.

September 23, 2019
·
1 min read
Business

Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris

Entered into a license agreement to promote and distribute the second brand TECERIS for the anticancer agent eribulin mesylate (eribulin) in India.

September 23, 2019
·
5 min read
Policy

DAFOH Discusses Role of Forced Organ Harvesting as a Tool of Religious Persecution and Genocide in China

Doctors Against Forced Organ Harvesting, a leading medical ethics NGO, will host a panel discussion event during the United Nations General Assembly to highlight the crimes of human forced organ harvesting and genocide in China.

September 23, 2019
·
1 min read
Business

Akcea Sees Abrupt Departure of Three Senior Executives

As Akcea Therapeutics moves forward with a second attempt to gain regulatory approval for Waylivra, it will do so without a number of its C-suite executives.

September 23, 2019
·
3 min read
·
Alex Keown
Business

Omega Therapeutics Debuts to Develop Epigenetic Drugs

Epigenetics is the study of changes in gene expression that don’t involve changes to the DNA sequence.

September 23, 2019
·
3 min read
·
Mark Terry
Drug Development

Ipsen’s Dysport Effective in Treating Limb Spasticity

Ipsen announced positive data from the ENGAGE Phase IIIb/IV clinical trial of Dysport (abobotulinumtoxinA) to treat upper and lower limb spasticity in adults with a Guided Self-rehabilitation Contract.

September 23, 2019
·
2 min read
·
Mark Terry
Business

Clovis Moves into Radiopharmaceuticals Through $12 Million Deal with 3B

Clovis Oncology plunked down $12 million in an upfront payment to Germany-based 3B Pharmaceuticals for licensing rights to peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein alpha.

September 23, 2019
·
2 min read
·
Alex Keown
3 Important Reasons for Life Sciences Professionals to Have Great LinkedIn Profiles

Hre are three key reasons professionals in life sciences need to have a solid LinkedIn profile.

September 23, 2019
·
3 min read
·
Dana Dunbar, Career Branding Strategist